Company / Debt per Share
Cytokinetics Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$2051.44
FY2025
5-year range
$0.56 / $2051.44
FY2021-FY2025
Trend
+33555.7%
vs FY2024
Sector context
#2 of 82
Health Care
What the data says
Debt per Share changed +33556% YoY in FY2025, a notable deviation from the 9-year average annual change of +3865%.
Based on SEC 10-K filings.
2051.44 in FY2025 with a 5-year CAGR of +400.9%. Ranks 2nd among 82 companies in Health Care.
Increased from $6.74 to $2051.44 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +544.6%
- 5-Year CAGR
- +400.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 82This company $2051.44 Sector average $151.59
▼
+1253.3% above sector average
Key checks
Key Insights
- In FY2025, debt per share increased 33555.7% year-over-year.
- Ranks #2 out of 82 companies in the Health Care sector.
- Lowest debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2051.44 | +33555.7% |
| FY2024 | $6.10 | -9.6% |
| FY2023 | $6.74 | -12.0% |
| FY2022 | $7.66 | +1271.3% |
| FY2021 | $0.56 | -14.2% |
| FY2020 | $0.65 | -14.5% |
| FY2019 | $0.76 | -1.8% |
| FY2018 | $0.78 | +31.6% |
| FY2017 | $0.59 | -19.9% |
| FY2016 | $0.74 | +98.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026